Maxwell Biomedical
San Diego
About Maxwell Biomedical
Maxwell Biomedical is developing the first of its kind device designed to deliver imperceptible, shock-free termination of each, and every episode of atrial fibrillation. Maxwell device monitors, diagnoses and if AF is detected, performs anti-AFib pacing called SRT to restore normal sinus rhythm. Fully Integrated AF Care System | Spatial Resynchronization Therapy and Patient Management - Only Technology to Monitoring, Diagnose AF and Deliver Imperceptible Therapy - Detect & convert AF back to SR -> Reduce AF Density/Burden, slow or stop disease progression - Cloud-based tele-health and remote patient management
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: Seed
- Last round: Seed (Jan 2021)
- Website: maxwellbiomedical.com
- Phone: +1 619 630 0364
Industries & Categories
Health Care, Medical, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/maxwell-biomedical-81598 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.